Work

P-177 Safety, Tolerability, and Pharmacokinetics of the Intestine-Restricted Oral Pan-Jak Inhibitor TD-1473 After Single and Multiple Oral Doses in Healthy Subjects

Year: 2017

Type: conference-abstract

Source: Inflammatory Bowel Diseases

DOI: 10.1097/01.mib.0000512693.33042.3d

Authors: Brian C. Ferslew, Claire D. Sherman, Deanna D. Nguyen, Richard Graham

Institution: Theravance Biopharma (United States)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2811037909

Cites:

Cited by: 1

Related to: 10